Related Experiment Video
Updated: May 10, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
[Electrical cardioversion for non-valvular atrial fibrillation--underestimated risk for thromboembolic
1Medizinische Klinik II, Schwerpunkt Kardiologie/Pneumologie, Klinikum Idar-Oberstein. h.klein@io.shg-kliniken.de
Insights
Electrical cardioversion for atrial fibrillation increases thromboembolism risk, even with anticoagulation. Enhanced anticoagulation post-procedure may mitigate this risk.
Area of Science:
- Cardiology
- Vascular Medicine
- Clinical Electrophysiology
Background:
- Electrical cardioversion aims to restore normal heart rhythm in non-valvular atrial fibrillation patients.
- Established risk of thromboembolism (5%) exists with inadequate anticoagulation before and after cardioversion.
- A lesser-known increased thromboembolic risk is observed even with standard anticoagulation during cardioversion.
Purpose of the Study:
- To highlight the increased risk of thromboembolism following electrical cardioversion in non-valvular atrial fibrillation patients on standard anticoagulation.
- To compare the thromboembolic risk associated with cardioversion versus non-cardioversion periods.
- To explore potential strategies for mitigating this procedural risk.
Main Methods:
- Analysis of thromboembolic complication rates in patients undergoing electrical cardioversion for non-valvular atrial fibrillation.
- Comparison of observed thromboembolic risk during the month post-cardioversion with baseline monthly risks (0.13-0.2%) from clinical trials.
- Discussion of anticoagulation strategies, including the potential benefit of intensified anticoagulation (INR > 2.5) in the early post-cardioversion period.
Main Results:
- The monthly risk of thromboembolism following cardioversion is 3-6 times higher than the baseline risk in non-valvular atrial fibrillation patients on standard anticoagulation.
- This increased risk is observed despite patients being on established anticoagulation regimens.
- The risk associated with electrical versus pharmacological cardioversion remains to be fully elucidated.
Conclusions:
- Electrical cardioversion, while beneficial for symptom management, carries an underappreciated increased risk of thromboembolism in non-valvular atrial fibrillation patients.
- This procedural risk necessitates acknowledgment and careful management.
- Intensified anticoagulation for 10-14 days post-cardioversion may be a viable strategy to minimize thromboembolic complications.
Abstract:
Electrical cardioversions are performed to restore sinus rhythm in patients with non-valvular atrial fibrillation to improve symptoms. It has been known for decades that cardioversion without adequate anticoagulation for 3-4 weeks prior to and for 4 weeks after cardioversion results in thromboembolic complication of about 5%. It is much less known that cardioversion is also associated with a higher risk of thromboembolism (stroke, peripheral embolism) in patients treated with usual anticoagulation. The control arms (warfarin) of the three studies with the new anticoagulants dabigatran, rivaroxaban, and apixaban for the prevention of thromboembolism in non-valvular atrial fibrillation report a monthly thromboembolic risk of 0,13-0,2%. The risk for thromboembolic complication in the month following cardioversion is about three to six times higher than without cardioversion in patients with non-valvular atrial fibrillation treated with usual anticoagulation. Since most cardioversions are performed by DC shock it is not known whether electrical and pharmacological cardioversions carry the same risk for thromboembolism. Although thromboembolic complications do not often occur following cardioversion the increased risk due to this procedure should be acknowledged. Strict anticoagulation (e. g. INR value > 2,5) in the first 10-14 days following cardioversion could possibly minimize the risk of thromboembolism.
Related Concept Videos
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Venous Thrombosis III: Interprofessional Care
Dysrhythmias VI: Management of Dysrhythmias
Dysrhythmias V: Evaluating Dysrhythmias
Cardiac Catheterization IV: Nursing Management
Dysrhythmias II: Classification of Tachyarrhythmias

